The ATLAS Randomised Clinical Trial: What do the Superiority Results Mean for Subcutaneous ICD Therapy and Sudden Cardiac Death Prevention as a Whole?

This review sets out the key evidence comparing subcutaneous ICDs (S-ICDs) and transvenous ICDs and uses it to empower clinical cardiologists and those who implant ICDs to make optimum patient selections for S-ICD use. The evidence demonstrates that clinical trials performed until recently have prov...

Descripción completa

Detalles Bibliográficos
Autor principal: Rordorf, Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Radcliffe Cardiology 2022
Materias:
Implantable Devices
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9611761/
https://www.ncbi.nlm.nih.gov/pubmed/36313240
http://dx.doi.org/10.15420/aer.2022.11.S1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9611761/
https://www.ncbi.nlm.nih.gov/pubmed/36313240
http://dx.doi.org/10.15420/aer.2022.11.S1

Ejemplares similares